Additional file 1: Table S3. of Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC

Patient and Tumour Characteristics, Responses to Neoadjuvant Chemotherapy (n = 33). (DOCX 56 kb

Additional file 3: Table S1. of Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumour cell death induced by NAC

Comparison of Tumour-infiltrating Lymphocytes (TILs) in Primary Breast Tumours and Pre-NAC(1) ALN(2) Metastatic Tumours in Women with LLABCs(3). There was no significant difference between the levels of TILs in primary breast tumours and axillary metastatic tumour deposits. Table S2. Correlations of Tumour-infiltrating Lymphocyte Subsets in Primary Breast Tumours and ALN (1) Metastatic Tumours in Women with LLABCs(2) [Spearman’s Correlation Coefficient (rho)] (n = 20). There was a positive correlation between CD8+ T and CD56+ NK cells infiltrating primary breast cancers and the tumour deposits in metastatic ALNs (rho=0.514, p =0.020; rho=0.721, p < 0.001, respectively). There was no correlation, however, between CD4+, FOXP3+ and CTLA-4+ T cells infiltrating the primary and metastatic tumours. (DOCX 26 kb